Shuhang wang, PhD

Rare Disease Specialist

Shuhang Wang

Beijing, Beijing Municipality

PI on 3 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Hinman syndrome
Neurofibromatosis type 1

Clinical trials (3)

NCT06553365
NCT06834438
NCT07366658

Verify independently

ClinicalTrials.gov PI search for Shuhang wang, PhD

Other specialists for Hinman syndrome

Peers ranked by clinical-trial PI role, publications, and verification quality.

Global Clinical Leader
Daiichi Sankyo
Helen McShane
University of Oxford
Mikhail Samsonov
R-Pharm
BioNTech Responsible Person
BioNTech SE
Charles Theuer, MD, MD
Tracon Pharmaceuticals Inc.
CA
Leona Holmberg
Fred Hutch/University of Washington Cancer Consortium
WA
Michael Kurman, MD
Traws Pharma, Inc.
Emilie Rohmer
Zimmer Biomet

See all specialists for Hinman syndrome →

← Back to specialists directory